World Health Organization Pulmonary Hypertension Group 2

Pulmonary hypertension due to left heart disease in the adult - A summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation

James C. Fang, Teresa Demarco, Michael M. Givertz, Barry A Borlaug, Gregory D. Lewis, J. Eduardo Rame, Mardi Gomberg-Maitland, Srinivas Murali, Robert Frantz, Dana McGlothlin, Evelyn M. Horn, Raymond L. Benza

Research output: Contribution to journalArticle

133 Citations (Scopus)

Abstract

Pulmonary hypertension associated with left heart disease is the most common form of pulmonary hypertension encountered in clinical practice today. Although frequently a target of therapy, its pathophysiology remains poorly understood and its treatment remains undefined. Pulmonary hypertension in the context of left heart disease is a marker of worse prognosis and disease severity, but whether its primary treatment is beneficial or harmful is unknown. An important step to the future study of this important clinical problem will be to standardize definitions across disciplines to facilitate an evidence base that is interpretable and applicable to clinical practice. In this current statement, we provide an extensive review and interpretation of the current available literature to guide current practice and future investigation. At the request of the Pulmonary Hypertension (PH) Council of the International Society for Heart and Lung Transplantation (ISHLT), a writing group was assembled and tasked to put forth this document as described above. The review process was facilitated through the peer review process of the Journal of Heart and Lung Transplantation and ultimately endorsed by the leadership of the ISHLT PH Council.

Original languageEnglish (US)
Pages (from-to)913-933
Number of pages21
JournalJournal of Heart and Lung Transplantation
Volume31
Issue number9
DOIs
StatePublished - Sep 2012

Fingerprint

Pulmonary Hypertension
Heart Diseases
Heart-Lung Transplantation
Peer Review
Therapeutics

Keywords

  • heart failure
  • heart transplant
  • left heart disease
  • left ventricular assist device
  • pulmonary hypertension
  • right heart failure

ASJC Scopus subject areas

  • Transplantation
  • Cardiology and Cardiovascular Medicine
  • Pulmonary and Respiratory Medicine
  • Surgery

Cite this

World Health Organization Pulmonary Hypertension Group 2 : Pulmonary hypertension due to left heart disease in the adult - A summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation. / Fang, James C.; Demarco, Teresa; Givertz, Michael M.; Borlaug, Barry A; Lewis, Gregory D.; Rame, J. Eduardo; Gomberg-Maitland, Mardi; Murali, Srinivas; Frantz, Robert; McGlothlin, Dana; Horn, Evelyn M.; Benza, Raymond L.

In: Journal of Heart and Lung Transplantation, Vol. 31, No. 9, 09.2012, p. 913-933.

Research output: Contribution to journalArticle

Fang, James C. ; Demarco, Teresa ; Givertz, Michael M. ; Borlaug, Barry A ; Lewis, Gregory D. ; Rame, J. Eduardo ; Gomberg-Maitland, Mardi ; Murali, Srinivas ; Frantz, Robert ; McGlothlin, Dana ; Horn, Evelyn M. ; Benza, Raymond L. / World Health Organization Pulmonary Hypertension Group 2 : Pulmonary hypertension due to left heart disease in the adult - A summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation. In: Journal of Heart and Lung Transplantation. 2012 ; Vol. 31, No. 9. pp. 913-933.
@article{f1bc4e3cb29a453e8d7d6b0d0d1b671e,
title = "World Health Organization Pulmonary Hypertension Group 2: Pulmonary hypertension due to left heart disease in the adult - A summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation",
abstract = "Pulmonary hypertension associated with left heart disease is the most common form of pulmonary hypertension encountered in clinical practice today. Although frequently a target of therapy, its pathophysiology remains poorly understood and its treatment remains undefined. Pulmonary hypertension in the context of left heart disease is a marker of worse prognosis and disease severity, but whether its primary treatment is beneficial or harmful is unknown. An important step to the future study of this important clinical problem will be to standardize definitions across disciplines to facilitate an evidence base that is interpretable and applicable to clinical practice. In this current statement, we provide an extensive review and interpretation of the current available literature to guide current practice and future investigation. At the request of the Pulmonary Hypertension (PH) Council of the International Society for Heart and Lung Transplantation (ISHLT), a writing group was assembled and tasked to put forth this document as described above. The review process was facilitated through the peer review process of the Journal of Heart and Lung Transplantation and ultimately endorsed by the leadership of the ISHLT PH Council.",
keywords = "heart failure, heart transplant, left heart disease, left ventricular assist device, pulmonary hypertension, right heart failure",
author = "Fang, {James C.} and Teresa Demarco and Givertz, {Michael M.} and Borlaug, {Barry A} and Lewis, {Gregory D.} and Rame, {J. Eduardo} and Mardi Gomberg-Maitland and Srinivas Murali and Robert Frantz and Dana McGlothlin and Horn, {Evelyn M.} and Benza, {Raymond L.}",
year = "2012",
month = "9",
doi = "10.1016/j.healun.2012.06.002",
language = "English (US)",
volume = "31",
pages = "913--933",
journal = "Journal of Heart and Lung Transplantation",
issn = "1053-2498",
publisher = "Elsevier USA",
number = "9",

}

TY - JOUR

T1 - World Health Organization Pulmonary Hypertension Group 2

T2 - Pulmonary hypertension due to left heart disease in the adult - A summary statement from the Pulmonary Hypertension Council of the International Society for Heart and Lung Transplantation

AU - Fang, James C.

AU - Demarco, Teresa

AU - Givertz, Michael M.

AU - Borlaug, Barry A

AU - Lewis, Gregory D.

AU - Rame, J. Eduardo

AU - Gomberg-Maitland, Mardi

AU - Murali, Srinivas

AU - Frantz, Robert

AU - McGlothlin, Dana

AU - Horn, Evelyn M.

AU - Benza, Raymond L.

PY - 2012/9

Y1 - 2012/9

N2 - Pulmonary hypertension associated with left heart disease is the most common form of pulmonary hypertension encountered in clinical practice today. Although frequently a target of therapy, its pathophysiology remains poorly understood and its treatment remains undefined. Pulmonary hypertension in the context of left heart disease is a marker of worse prognosis and disease severity, but whether its primary treatment is beneficial or harmful is unknown. An important step to the future study of this important clinical problem will be to standardize definitions across disciplines to facilitate an evidence base that is interpretable and applicable to clinical practice. In this current statement, we provide an extensive review and interpretation of the current available literature to guide current practice and future investigation. At the request of the Pulmonary Hypertension (PH) Council of the International Society for Heart and Lung Transplantation (ISHLT), a writing group was assembled and tasked to put forth this document as described above. The review process was facilitated through the peer review process of the Journal of Heart and Lung Transplantation and ultimately endorsed by the leadership of the ISHLT PH Council.

AB - Pulmonary hypertension associated with left heart disease is the most common form of pulmonary hypertension encountered in clinical practice today. Although frequently a target of therapy, its pathophysiology remains poorly understood and its treatment remains undefined. Pulmonary hypertension in the context of left heart disease is a marker of worse prognosis and disease severity, but whether its primary treatment is beneficial or harmful is unknown. An important step to the future study of this important clinical problem will be to standardize definitions across disciplines to facilitate an evidence base that is interpretable and applicable to clinical practice. In this current statement, we provide an extensive review and interpretation of the current available literature to guide current practice and future investigation. At the request of the Pulmonary Hypertension (PH) Council of the International Society for Heart and Lung Transplantation (ISHLT), a writing group was assembled and tasked to put forth this document as described above. The review process was facilitated through the peer review process of the Journal of Heart and Lung Transplantation and ultimately endorsed by the leadership of the ISHLT PH Council.

KW - heart failure

KW - heart transplant

KW - left heart disease

KW - left ventricular assist device

KW - pulmonary hypertension

KW - right heart failure

UR - http://www.scopus.com/inward/record.url?scp=84864924644&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864924644&partnerID=8YFLogxK

U2 - 10.1016/j.healun.2012.06.002

DO - 10.1016/j.healun.2012.06.002

M3 - Article

VL - 31

SP - 913

EP - 933

JO - Journal of Heart and Lung Transplantation

JF - Journal of Heart and Lung Transplantation

SN - 1053-2498

IS - 9

ER -